Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination

OBJECTIVES: Coronavirus 2019 vaccine responses in rare autoimmune rheumatic diseases (RAIRDs) remain poorly understood; in particular there is little known about whether people develop effective T cell responses. We conducted an observational study to evaluate the short-term humoral and cell-mediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumber, Leher, Gomez, Nancy, Hopkins, Georgina, Tucis, Davis, Bartlett, Laura, Ayling, Kieran, Vedhara, Kavita, Steers, Graham, Chakravorty, Mithun, Rutter, Megan, Jackson, Hannah, Tighe, Patrick, Ferraro, Alastair, Power, Sheila, Pradère, Marie-Josèphe, Onion, David, Lanyon, Peter C, Pearce, Fiona A, Fairclough, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619726/
https://www.ncbi.nlm.nih.gov/pubmed/36250898
http://dx.doi.org/10.1093/rheumatology/keac574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619726/
https://www.ncbi.nlm.nih.gov/pubmed/36250898
http://dx.doi.org/10.1093/rheumatology/keac574

Ejemplares similares